The Week in Review: January 26 – February 2, 2018

Friday, February 2, 2018 News Recap: From the Uh-Oh Department: HCV Can Reactivate with Treatment of Non-hepatic Cancer. Hepatitis C virus (HCV) reactivation occurred in approximately 1 out of 5 patients treated for non-hepatic cancer, posing renewed risk for hepatic injury and possibly complicating the cancer treatment. Compensation Update: Compensation – New Update for 86-90 Late Claims. If you or a family member received a blood transfusion o...

SVR for HCV with no advanced liver disease greatly reduces mortality risk

Patients with hepatitis C without advanced liver disease who achieved sustained virologic response with direct-acting antiviral therapy had significantly reduced all-cause mortality rates compared with both treated patients who did not achieve SVR and untreated patients, according to a recently published data. “These data strongly support a clinically significant benefit of DAA treatment in patients without clinically apparent advanced liver disease and e

Smoking reduces survival after liver cancer diagnosis for people with viral hepatitis

People with viral hepatitis who smoked were three times more likely to die after being diagnosed with liver cancer (hepatocellular carcinoma, HCC), according to a study of Swiss patients published in Liver International. Whereas non-smokers lived for a median of 3.2 years after diagnosis, smokers died after a median of 18 months. Smoking had a similar impact on survival in those who did not receive curative treatment in the form of liver resection (surger

The Week in Review: December 8 – December 15, 2017

Friday, December 15, 2017 News Recap: 8 updates on liver transplantation outcomes for 2017: Over the past year, researchers and physicians have reported changes among the leading indications on the liver waitlist and improvements in transplantation outcomes. In this article, Healio.com/Hepatology presents recent reports on waitlist mortality risks, improved pediatric liver transplantation outcomes, and the positive effects of HCV treatment on transpl...

Liver Damage Worse in Women With HBV/HCV Coinfection, Risky Drinking

Coinfection with hepatitis B and C virus (HBV/HCV) combined with risky alcohol consumption enhances liver damage mechanisms to a greater extent in women than in men, according to a recent study in PLoS One. Hepatitis infection and risky drinking are major risk factors for liver disease, and coinfection with both HBV and HCV is more likely to progress to cirrhosis than single infections. Pooled data from 2 national surveys in Italy allowed the estimation o

The Week in Review: December 1 – December 8, 2017

Friday, December 8, 2017 News Recap: URGENT BC Patient and Caregiver Input Request: Vosevi. We need to hear your voice! Patient and Caregiver input is requested by BC PharmaCare on Gilead’s combo of sofosbuvir, velpatasvir, and voxilaprevir (SOF-VEL-VOX or Vosevi™) for Genotypes 1-6. Personal Stories This week we have two great stories of triumphing over HepC: Aidain’s ‘I will never forget the day I found out I had hepatitis c’, and Patric...

Hep C and me: ‘I was nauseous all the time. I couldn’t gain weight. My skin was itchy and raw’

WHEN I WAS diagnosed with Hepatitis C in the 1990s I was told I’d loads of more serious problems I had to deal with first. I remember getting the result and the doctor turning to me and saying, Patrick, it’ll kill you in 30 years so don’t worry about it. I was using drugs. I’d washed up to an addiction service, exhausted from the drugs, exhausted from the chaos of it all. I was tested. I was given advice that at the time that somehow made sense. Thirty

McGill study finds people infected with HIV more likely to develop fatty liver

Fatty liver is among the most frequent causes of liver disease in Canada and in Western countries and is one of the main indications for liver transplant. For some time, researchers have suspected that people living with HIV could be at higher risk of developing liver disease, which, as a result of longer life expectancy thanks to antiretroviral therapy, has become the major cause of their mortality in North America. Due to the invasiveness of liver biops

The Week in Review: November 4 – November 10, 2017

Friday, November 10, 2017 News Recap: Canada: Updated List of Physicians in British Columbia Currently Treating Hepatitis B and/or Hepatitis C. HepCBC has updated its list of Doctors in BC who treat HCV and HBV. Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients. Many of the 300,000 HCV-infected Canadians live in under-served and remote areas without access to HCV healthcare specialists. Telemedicine (T...

HCV-related liver disease on the rise in women

Hepatitis C virus (HCV)-related complications are increasing among women, according to a national cohort study. Typically, men have a higher risk of progression to liver disease than women because men develop liver disease from HCV at a higher rate than women. “We found that women had increase of incidence of liver disease at a similar rate to men.  Since the mortality rate was lower in women, this suggests that women will have a larger contribution to t